Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Regeneron
Regeneron
Priority Review for Zaltrap
Yahoo/Zacks
Thu, 04/5/12 - 09:12 pm
Zaltrap
Regeneron
Sanofi
colorectal cancer
Regeneron cholesterol drug faces sudden challenge
Reuters
Mon, 03/26/12 - 12:10 pm
Amgen
Regeneron
PCSK9 inhibitor
AMG145
REGN727
Sanofi
20 Biotech Stocks Being Bought Up By Hedge Funds
Seeking Alpha
Sun, 03/25/12 - 11:38 am
Achillion
Amylin
Ariad Pharmaceuticals
Aveo Pharmaceutical
Cell Therapeutics
EXACT Sciences
Idenix
Exelixis
Halozyme
Lexicon Pharmaceuticals
Nektar
Momenta
ONYX Pharmaceuticals
Optimer Pharmaceuticals
PDL Biopharma
Questcor Pharmaceuticals
Santarus
Spectrum Pharmaceuticals
Regeneron
Vivus
Next big cholesterol drugs in focus at meeting
Reuters
Thu, 03/22/12 - 11:28 am
cardiology
PCSK9 inhibitor
REGN 727
Amgen
Merck
Regeneron
A Drug Class Back From the Dead?
Motley Fool
Wed, 03/14/12 - 09:42 am
Pfizer
Regeneron
JNJ
Sanofi
AstraZeneca
FDA
NGF blockers
Don't Expect Too Much From New Pain Drugs, Analyst Says
Forbes
Tue, 03/13/12 - 11:07 am
painkillers
NGF blockers
Amgen
Regeneron
JNJ
FDA panel recommends lifting research hold on nerve-blocking pain drugs, despite safety risk
Yahoo/AP
Mon, 03/12/12 - 05:47 pm
FDA
painkillers
Pfizer
JNJ
Regeneron
arthritis
U.S. Regulators Probes Resuming Painkiller Trials Tied to Joint Failure
Bloomberg
Thu, 03/8/12 - 09:55 am
Pfizer
JNJ
FDA
joint failure
painkillers
fulranumab
Sanofi
Regeneron
tanezumab
REGN475/SAR164877
1-Star Stocks Poised to Plunge: Regeneron?
Motley Fool
Thu, 02/16/12 - 11:21 am
Regeneron
Regeneron climbs after raising Eylea sales outlook
Yahoo/AP
Mon, 02/13/12 - 08:01 pm
Regeneron
Eylea
6 Drug Stocks Unworthy of Biotech Bull Market
TheStreet.com
Tue, 02/7/12 - 10:49 am
Cytori
Regeneron
Human Genome Sciences
Galena Biopharma
BioSante
EntreMed
3 Lessons From the J.P. Morgan Health-Care Confab
Motley Fool
Mon, 01/16/12 - 10:43 am
SOMA
Regeneron
Vertex
Gilead
GSK
Biocryst
Dendreon
InterMune
Biotechs: Has The Law Of Gravity Been Suspended?
Seeking Alpha
Sat, 01/14/12 - 11:27 am
Celgene
Dendreon
Medivation
Regeneron
ViroPharma
Biotech Investors Buoyed By Signs Of Speedier Drug Launches
Seeking Alpha
Mon, 01/9/12 - 10:40 am
drug launches
Dendreon
Incyte
Human Genome Sciences
Regeneron
Seattle Genetics
Vertex
Dendreon, JAZZ and Regeneron Among Best Stock Price Performers
Yahoo/Wall St. Cheat Sheet
Sat, 01/7/12 - 01:26 pm
Dendreon
Jazz
Regeneron
Biotech 2012 Kickoff Party: Investor Preview
TheStreet.com
Wed, 01/4/12 - 10:22 am
Celgene
Vivus
Dendreon
Gilead
Incyte
YM BioSciences
ONYX Pharmaceuticals
Seattle Genetics
Vertex
Amarin
Biomarin
Biogen Idec
Regeneron
Merck KGaA
Human Genome Sciences
Clovis Oncology
Roche
Ariad
Immunogen
Medivation
Geron
InterMune
Indenix
Amag Pharmaceuticals
Mesoblast
Arena
MannKind
Keryx
Spectrum Pharmaceuticals
Regeneron settles with Genentech over eye drug
Yahoo/AP
Tue, 01/3/12 - 11:29 am
Regeneron
Genentech
Eyelea
Pharma winners of 2011 could keep surging next year
Investorplace
Wed, 12/28/11 - 12:08 pm
Amgen
Biogen Idec
Celgene
Gilead
Pharmasset
Alexion
Regeneron
Regeneron Drops as Eye Drug Shown Similar to Roche's Lucentis
Bloomberg Businessweek
Mon, 12/5/11 - 12:28 pm
Roche
Lucentis
Regeneron
Eyela
wet-AMD
December Catalysts for Drug and Biotech Stocks
Minyanville
Sat, 12/3/11 - 11:11 am
Pfizer
Aveo Pharmaceutical
Affymax
Amgen
Antares Pharma
Celgene
ONYX Pharmaceuticals
Seattle Genetics
Micromet
YM BioSciences
Regeneron
BioSante
Pages
« first
‹ previous
…
43
44
45
46
47
48
49
50
51
next ›
last »